Cargando…
Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations
BACKGROUND: Cystic fibrosis (CF) is a multisystem disease that often requires otolaryngology care. Individuals with CF commonly have chronic rhinosinusitis but also present with hearing loss and dysphonia. Given these manifestations of CF, otolaryngologists are frequently involved in the care of pat...
Autores principales: | Kimple, Adam J., Senior, Brent A., Naureckas, Edward T., Gudis, David A., Meyer, Ted, Hempstead, Sarah E., Resnick, Helaine E., Albon, Dana, Barfield, Wayne, Benoit, Margo McKenna, Beswick, Daniel M., Callard, Eliza, Cofer, Shelagh, Downer, Veronica, Elson, E. Claire, Garinis, Angela, Halderman, Ashleigh, Hamburger, Lisa, Helmick, Meagan, McCown, Michael, McKinzie, Cameron J., Phan, Hanna, Rodriguez, Kenneth, Rubenstein, Ronald C., Severin, Ashley, Shah, Gopi, Shenoy, Ambika, Sprouse, Brittney, Virgin, Frank, Woodworth, Bradford A., Lee, Stella E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545592/ https://www.ncbi.nlm.nih.gov/pubmed/35089650 http://dx.doi.org/10.1002/alr.22974 |
Ejemplares similares
-
In their own words: disaster and emotion, suffering, and mental health
por: McKinzie, Ashleigh Elain
Publicado: (2018) -
The Influenza A Virus M2 Protein trans-Complementation System Offers a Set of Tools for the Undergraduate Virology Laboratory
por: Grantham, Michael L., et al.
Publicado: (2019) -
Effect of Hospital Linens on Unit-Acquired Pressure Injuries for Adults in Medical ICUs: A Cluster Randomized Controlled Trial
por: Montague-McCown, Mary, et al.
Publicado: (2021) -
Secondary Structural Model of MALAT1 Becomes Unstructured in Chronic Myeloid Leukemia and Undergoes Structural Rearrangement in Cervical Cancer
por: Wang, Matthew C., et al.
Publicado: (2021) -
Cost-effectiveness of implementing routine hearing screening using a tablet audiometer for pediatric cystic fibrosis patients receiving high-dose IV aminoglycosides
por: Huang, Shirley P, et al.
Publicado: (2021)